UnknownNot Applicable

Application of UCPCR as a Testing Tool for Identification of MODY Patients in the UAE

United Arab Emirates778 participantsStarted 2015-04-01

Plain-language summary

The study aims to investigate the validity of 2 hour post-prandial UCPCR test in paediatric and adult patients with diabetes duration greater than 2 and 5 years, respectively, for the purposes of distinguishing between patients with type 1 diabetes and MODY in the UAE population.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients with age and age of diabetes onset of \<18 years * patients with age of ≥18 years and age of diabetes onset of ≤30 years Exclusion Criteria: \- patients with age of ≥18 years and age of diabetes onset of \>30 years

What they're measuring

Urinary C-peptide Creatinine Ratio (UCPCR)

Timeframe: 2 hours post-prandial

Trial details

NCT IDNCT03607604

SponsorImperial College London Diabetes Centre

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-12-31

View on ClinicalTrials.gov More Diabetes Mellitus, Type 1 trials